Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Aochi Pharmaceutical Technology is a specialized pharmaceutical research and development organization based in Shanghai, China. Founded in 2014, the company focuses on providing high-end formulation development and CMC (Chemistry, Manufacturing, and Controls) services to the global pharmaceutical industry. Their technical expertise encompasses complex drug delivery systems, including ophthalmic preparations, injectable emulsions, and sustained-release microspheres. As a Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), Aochi Pharma supports clients from early-stage drug discovery through clinical trial material production and regulatory submission. The company operates advanced laboratory facilities and pilot production lines designed to meet international quality standards. Aochi Pharma is particularly active in the development of improved new drugs and high-barrier generic products, bridging the gap between innovative research and commercial manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Aochi Pharmaceutical Technology.